by Devices and Pharma | May 5, 2024 | FDA_Programs, Industry Information, Pharmaceuticals, US-FDA
Rare Pediatric Disease Priority Review Voucher (PRV) program To expedite the review and approval of pediatric disease therapies Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation My Account Contact Expedite Development...
by Devices and Pharma | May 3, 2024 | Industry Information, Med-Devices, Pharmaceuticals, US-FDA
Navigating Complex Regulations Regulatory Guidance for Medical Devices & Pharmaceuticals At Medical Devices and Pharma, we specialize in providing top-tier regulatory consulting services tailored to the medical device and pharmaceutical industries. Our deep...
by Devices and Pharma | May 3, 2024 | FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
Drug Innovation - Tisotumab vedotin-tftv, marketed as Tivdak For Recurrent or Metastatic Cervical Cancer Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Product Approval for Cervical Cancer Drug Exciting...
by Devices and Pharma | May 3, 2024 | Consumer Information, FDA Approvals, Industry News, New Drugs, New Pharma Products, Pharmaceuticals, Product-Innovation, US-FDA
FDA Drug Innovation - Anktiva Treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact New Drug Approval In a significant development for...
by Devices and Pharma | May 3, 2024 | Alerts, Alerts-Pharma, Consumer Information, Consumer Safety, FDA Safety Communication, Industry News, Pharmaceuticals, US-FDA
FDA Health Alert Regarding Rare Pregnancy Complication Risk of intrahepatic cholestasis of pregnancy (ICP) Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact FDA Safety Communication In a recent health safety...
by Devices and Pharma | Apr 30, 2024 | Alerts, Alerts-Device, Class I Recalls, Industry News, Med-Devices, Pharmaceuticals, Product Recalls
Recall Notice for BioMérieux VITEK 2 AST Kit An anomaly in Ceftriaxone concentrations results in misreading bacterial susceptibility Home About Consumer Medical Devices Pharma AI Regulatory Quality News Enforcement Alerts Innovation Contact Class I Recall Notice ...
